Verification of the Safety of Early Discharge in Patients After Acute ST-segment Myocardial Infarction
Last updated on April 2022Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 150
Inclusion Criteria
- Age ≥18 do ≤ 75 years
- Acute myocardial infarction with ST-segment elevation, treated with successful percutaneous coronary intervention within 12 hours from the onset of symptoms
- Left ventricle ejection fraction ≥ 45% by echocardiography
- ...
- Age ≥18 do ≤ 75 years
- Acute myocardial infarction with ST-segment elevation, treated with successful percutaneous coronary intervention within 12 hours from the onset of symptoms
- Left ventricle ejection fraction ≥ 45% by echocardiography
- Single- or two-vessel disease (stenosis of major epicardial artery ≥ 70%)
- Assumed good cooperation and social background
- Haemodynamic and rhythmic stability (Killip class I, no arrythmia requiring treatment occurring > 2 hours after PCI)
- Signed informed consent
Exclusion Criteria
- Contraindication of dual antiplatelet therapy or need for anticoagulation therapy
- Symptoms of residual ischemia
- Hihg risk of bleeding complications
- ...
- Contraindication of dual antiplatelet therapy or need for anticoagulation therapy
- Symptoms of residual ischemia
- Hihg risk of bleeding complications
- Participation in other clinical study
- Significant comorbidities or abnormalities in paraclinical tests, requiring additional evaluation within continuing hospitalization
Summary
- Conditions
- Acute Myocardial Infarction With ST-segment Elevation
- Coronary (Artery) Disease
- Early Discharge
- Primary Percutaneous Coronary Intervention
- Coronary Artery Disease
- Type
- Interventional
- Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
The aim of the study is to prove that early discharge (within 72 hours) in selected group of patients with low risk of follow-up complications after myocardial infarction with elevations of ST-segment, treated with primary percutaneous coronary intervention, is feasible and safe that early discharge...
The aim of the study is to prove that early discharge (within 72 hours) in selected group of patients with low risk of follow-up complications after myocardial infarction with elevations of ST-segment, treated with primary percutaneous coronary intervention, is feasible and safe that early discharge is comparable with the group of patients, discharged in a standard way accordingly with present practice and physician´s decision (usually 4th-7th day), thus it is not associated with higher incidence of complications in 90th day after myocardial infarction
Inclusion Criteria
- Age ≥18 do ≤ 75 years
- Acute myocardial infarction with ST-segment elevation, treated with successful percutaneous coronary intervention within 12 hours from the onset of symptoms
- Left ventricle ejection fraction ≥ 45% by echocardiography
- ...
- Age ≥18 do ≤ 75 years
- Acute myocardial infarction with ST-segment elevation, treated with successful percutaneous coronary intervention within 12 hours from the onset of symptoms
- Left ventricle ejection fraction ≥ 45% by echocardiography
- Single- or two-vessel disease (stenosis of major epicardial artery ≥ 70%)
- Assumed good cooperation and social background
- Haemodynamic and rhythmic stability (Killip class I, no arrythmia requiring treatment occurring > 2 hours after PCI)
- Signed informed consent
Exclusion Criteria
- Contraindication of dual antiplatelet therapy or need for anticoagulation therapy
- Symptoms of residual ischemia
- Hihg risk of bleeding complications
- ...
- Contraindication of dual antiplatelet therapy or need for anticoagulation therapy
- Symptoms of residual ischemia
- Hihg risk of bleeding complications
- Participation in other clinical study
- Significant comorbidities or abnormalities in paraclinical tests, requiring additional evaluation within continuing hospitalization
Tracking Information
- NCT #
- NCT02023983
- Collaborators
- Not Provided
- Investigators
- Not Provided